-
immunodeficiency virus type 1 with pol gene
mutations conferring multi-
dideoxynucleoside resistance". The
Journal of
Infectious Diseases. 177 (5): 1207–13...
- type III/lymphadenopathy-****ociated
virus (HTLV-III/LAV) by 2',3'-
dideoxynucleosides".
Proceedings of the
National Academy of
Sciences of the
United States...
- mg) in an
atmosphere of
hydrogen for 1 h to
obtain the
resultant dideoxynucleoside ( 2',3'-dideoxyuridine in this case). The dye
nucleotide to be used...
- primer.
Unlike Illumina,
Sanger sequencing uses
fluorescently labeled dideoxynucleoside triphosphates (ddNTPs) to
determine the
sequence of the DNA fragment...
-
pharmacology of 3'-azido-2',3'-dideoxythymidine (zidovudine) and
related dideoxynucleosides". N Engl J Med. 321 (11): 726–38. doi:10.1056/NEJM198909143211106...
- in
vitro infectivity and
cytopathic effect of
human foamy virus by
dideoxynucleosides". AIDS Res Hum Retroviruses. 12 (15): 1485–90. doi:10.1089/aid.1996...
-
elongation can no
longer occur. For example, E. coli DnaG will use 2',3'-
dideoxynucleoside 5'-triphosphates (ddNTPs) as substrates,
which act as
chain terminators...
-
Yamamoto N (June 1987). "Inhibitory
effect of 2',3'-didehydro-2',3'-
dideoxynucleosides on infectivity,
cytopathic effects, and
replication of
human immunodeficiency...
- Todaro,
Louis J.; Coffen,
David L. (2002-05-01). "Synthesis of the
dideoxynucleosides "ddC" and "CNT" from
glutamic acid, ribonolactone, and pyrimidine...
-
immunodeficiency virus and
inhibition by ribavirin, phosphonoformate, and 2',3'-
dideoxynucleosides". Antimicrob.
Agents Chemother. 31 (9): 1369–74. doi:10.1128/aac.31...
